The Trend Catcher | NIQ (+6%), TRI (+5%) Top Commercial Services-Market Research Sector; Pharma Outperforms as JNJ (+3.3%), LLY (+2.89%) Hit Records; AEP (+2.53%), WDFC (+2.47%) Approach Breakouts

NIQ Global Intelligence PLC
Thomson Reuters Corporation
HWH International Inc.
Gartner, Inc.
Advanced Micro Devices, Inc.

NIQ Global Intelligence PLC

NIQ

0.00

Thomson Reuters Corporation

TRI

0.00

HWH International Inc.

HWH

0.00

Gartner, Inc.

IT

0.00

Advanced Micro Devices, Inc.

AMD

0.00

Subscribe to "The Trend Catcher Topic," tracking hottest sectors & technical breakouts in real time daily, accompanying you every US stock trading day.


1. Leader industry as of 5:12 pm

NamePrice % ChgInd Group RankInd Grp Rnk 3 Mo Ago% Chg YTDInd Mkt Val (bil)
Comml Svcs-Market Rsrch3.16135121-30.3170.8
Beverages-Alcoholic2.92755513.4362.8
Medical-Distribution2.4611779-5.8206.0
Bldg-Maintenance & Svc2.41140111-18.330.6
Food - Packaged2.3697712.7831.8

Commercial Services - Market Research related stocks: NIQ Global Intelligence PLC(NIQ.US), Thomson Reuters Corporation(TRI.US), HWH International Inc.(HWH.US), Gartner, Inc.(IT.US)

Quick Summary and Outlook

US memory and AI hardware stocks staged a modest rebound on Monday, but the shift in market sentiment was unmistakable. The core catalyst was Nvidia's Kyber NVL144 rack, delayed by over 12 months to 2028 due to midplane yield issues. While Nvidia formally states its "roadmap is intact," the market is already aggressively repricing the competitive landscape.

Breadth was remarkably narrow. The S&P 500 (+0.88%) and Nasdaq (+1.43%) posted gains, but the equal-weight index rose a meager 0.04%. Gains in the Semiconductor Index (+2.15%) were acutely concentrated in stocks directly benefiting from the Kyber delay.

Winners Are Clear:

  • Advanced Micro Devices, Inc.(AMD.US) (+6.6%) was the day's biggest winner. The delay allows its MI500 "MegaPod" to compete against a less advanced 2-die Rubin Ultra, giving AMD a window to pitch a larger coherent scale-up domain. Goldman Sachs raised its price target from $450 to $640.
  • Broadcom Limited(AVGO.US) (+3.8%) saw its ASIC narrative strengthened. Nvidia's misstep makes Broadcom's custom silicon for Google, Meta, and Anthropic more attractive. The Apple contract renewal through 2031 also boosted sentiment.
  • Credo Technology(CRDO.US) (+10%) was the most direct beneficiary. A longer runway for NVLink copper means more AEC demand. The delay of CPO also extends the life of pluggable optics, directly helping its DSP/ZR product portfolio.

Pressured Areas:

Institutional View:
Major banks (MS, Citi, GS) are unanimous: the AI cycle is not over, but the axis of the trade has shifted. Investors must now verify prices, margins, orders, and customer share, rather than buying broad AI beta. The strongest theme is supply bottlenecks spreading from GPUs to DRAM, analog, equipment, and passive components.

Risks & Catalysts:
A leaked U.S. Treasury draft warns AI bubble risks resemble the 2000 dot-com era. Fed rate cut odds remain low. Key near-term catalysts include GPT 5.6 release, cloud CapEx guidance, and Samsung Electronics' official earnings report.


(Based on public research compiled on July 7, 2026. Not investment advice.)


2. Breaking Out Today as of 5:12 pm

SymbolComp RatingIndustry NameCurrent PricePrice % ChgMarket Cap (mil)
Johnson & Johnson(JNJ.US) 88Medical - Pharmaceuticals267.893.30624,263.6
Eli Lilly and Company(LLY.US) 99Medical - Pharmaceuticals1,234.702.891,130,146.2
Halozyme Therapeutics, Inc.(HALO.US) 98Medical - Profitable Biotech81.450.839,581.6

3. Near Breakouts as of 5:22 pm

SymbolComp RatingIndustry NameCurrent PricePrice % ChgMarket Cap (mil)
American Electric Power Company, Inc.(AEP.US) 79Utilities139.412.5373,987.4
WD-40 Company(WDFC.US) 94Chemicals-Specialty252.532.473,316.1

Subscribe to The Trend Catcher Topic / The Value Anchor Topic —unlock the full historical archive and never miss a weekly pick again.

More of Our Investment Philosophy>>


Disclaimer: The content is provided as general information only and should not be taken as investment advice. All the contents shall not be taken as a recommendation to buy or sell any security or financial instruments. Any action you take resulting from information, analysis, or commentary on this article is your responsibility. Please consult your investment advisor before making any investments.